Nevertheless, the combination of mLOAd703 and anti-PD-L1 was best in controlling the tumor growth of the distant lesion, whereas the combination with anti-TIM-3 had less effect on the distant tumor, but was most efficient in hampering the growth of the injected tumor lesion. The gene discussed is HAVCR2; the disease is neoplasm.